Plasma products

Virological Safety Aspects of Plasma Derivatives: Cannes (Developments in Biologicals)

Fred Brown

Plasma assisted decontamination of biological and chemical agents

edited by Selc̦uk Güc̦eri and Alexander Fridman ; assistant editors, Katie Gibson, Christine Haas

U.S. blood products markets, competition & trends: therapeutic apheresis & related technologies.

Medical Data International, Inc

FDA oversight: blood safety and the implications of pool sizes in the manufacture of plasma derivatives : hearing before the Subcommittee on Human Resources of the Committee on Government Reform and Oversight, House of Representatives, One Hundred Fifth Congress, first session, July 31, 1997.

United States. Congress. House. Committee on Government Reform and Oversight. Subcommittee on Human Resources

Virus inactivation in plasma products

volume editor, J.-J. Morgenthaler.

Public health 2000: immune globulin shortages--causes and cures : hearing before the Subcommittee on Human Resources of the Committee on Government Reform and Oversight, House of Representatives, One Hundred Fifth Congress, second session, May 7, 1998.

United States. Congress. House. Committee on Government Reform and Oversight. Subcommittee on Human Resources.

Blood safety, minimizing plasma product risks: hearing before the Subcommittee on Human Resources of the Committee on Government Reform and Oversight, House of Representatives, One Hundred Fifth Congress, second session, September 9, 1998.

United States. Congress. House. Committee on Government Reform and Oversight. Subcommittee on Human Resources

Coagulation factors: the state of safety : XVII ISTH Congress satellite symposion [sic], Washington

editor, P.M. Mannucci ; contributors, M. Chudy ... [et al.].

Blood Plasma Safety: Plasma Product Risks Are Low If Good Manufacturing Practices Are Followed

Bernice Steinhardt

Safe blood and blood products

World Health Organization